Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of ginger powder in preparation of drugs for treating viral influenza

A technology for viral colds and ginger powder, applied in antiviral agents, drug combinations, powder delivery, etc., can solve the problems of high infectivity and high incidence of viral colds

Inactive Publication Date: 2021-04-13
福建龙植生物科技有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the high incidence of viral influenza and high infectivity, there is still an urgent need to develop new drugs for the treatment of viral influenza

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of ginger powder in preparation of drugs for treating viral influenza
  • Application of ginger powder in preparation of drugs for treating viral influenza
  • Application of ginger powder in preparation of drugs for treating viral influenza

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0058] Example 1: H1N1 Infected Animals

[0059] For the detailed mouse breeding method and H1N1 infection method in this example, refer to the paper "Protective Effect of Xiaoer Ganmao Granules on Acute Lung Injury Induced by H1N1 Influenza Virus in Mice" by Zhu Haiyan, Cen Lifeng, Shi Xunlong, Duan Juanhui and Dai Zhi ("Chinese Proprietary Medicine "Volume 42, Issue 3, March 2020). This reference is incorporated by reference in its entirety into this application.

[0060] Virus strain Influenza virus type A1 (H1N1) mouse lung-adapted strain FM1 (batch number 20171002), provided by the Institute of Pharmaceutical Biotechnology, Chinese Academy of Medical Sciences, passed down and preserved by our laboratory (BSL-2 level), this laboratory has been filed and has operation Experimental qualification of influenza virus.

[0061] In this example, Babl / C mice were used, SPF level, male, initial body weight 17-18g, purchased from Sipro-Bikay Laboratory Animal Co., Ltd. (certific...

Embodiment 2

[0063] Embodiment 2: the change of animal body weight after ginger powder treats animal virus influenza

[0064] The mice were randomly divided into normal group, virus control group, positive drug control group (Rib group) and low, medium and high dose groups of ginger powder according to body weight. The ginger powder in the picture is also known as meal raw powder or SSF.

[0065] According to the dose, accurately weigh the drug, add 0.5% CMC, prepare the corresponding concentration, and dissolve / suspend by ultrasonication for 15 minutes. CMC is Carboxymethyl Cellulose (CMC), a water-soluble cellulose ether obtained by chemically modifying natural cellulose.

[0066] The mice in the normal group were given 0.5% CMC; the virus control group was given 0.5% CMC; the positive drug control group was given ribavirin 0.25g / kg; 300mg / kg, 600mg / kg.

[0067] The time for the first administration was 2 hours after the H1N1 FM1 virus nasal drop infection, and the interval between ...

Embodiment 3

[0075] Embodiment 3: the situation of animal death after ginger powder treats animal viral influenza

[0076] The situation of animal death after ginger powder treats animal virus influenza is as table 2 and Figure 2-4 shown.

[0077] Table 2: Death situation table of mice after infection (observation in 10 days)

[0078]

[0079] The results in Table 2 show that the survival rate of the middle-dose and low-dose mealy powder is 66.7% at 7 days (the last administration), which is 33.4% higher than that of the virus group. The 9-day (two days after drug withdrawal) survival rates were 16.6% and 33.3% for the medium dose and low dose of meal powder, which were significantly higher than those of the virus group (0.0%) and ribavirin group (0.0%).

[0080] figure 2 and image 3 It is a mouse weight-time scatter diagram, through which the body weight of mice at different times and different intervention methods can be clearly observed. figure 2 The results showed that th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of ginger powder in preparation of drugs for treating viral influenza, and particularly relates to application of superfine ground ginger powder in preparation of drugs for treating H1N1 viral influenza. The ginger powder can obviously improve the symptoms of H1N1 viral influenza.

Description

technical field [0001] The invention relates to the application of ginger powder in the preparation of medicine for treating viral influenza, in particular, the application of ultrafinely pulverized ginger powder in the preparation of medicine for treating H1N1 viral influenza. Background technique [0002] Viral colds, also known as upper respiratory tract infections, are common illnesses. When the body's immunity is low, external viruses can invade the human body through the upper respiratory tract, causing viral colds. Because the virus exists in the patient's respiratory tract, when the patient sneezes or coughs, the virus will be transmitted along with the droplets sprayed by the patient, so viral colds are highly contagious and difficult to control, causing great harm to humans. Big. [0003] Although there are many medicines for viral treatment of viral influenza now. However, due to the high incidence of viral influenza and high infectivity, there is still an urge...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9068A61K9/14A61P31/12A61P11/00A61P31/16
CPCA61K9/14A61K36/9068A61P11/00A61P31/12A61P31/16
Inventor 林成海万晓兰
Owner 福建龙植生物科技有限公司